1. HIV Treatment Update Todd Correll, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases/HIV University of North Carolina Hospitals November 2006 2. Objectives…
Clinical Skills for OSCEs Second Edition Editedby Neel L BurtonBSc MBBS(Land) AKC Senior House Officer inPsychiatry TheWarnefordHospital Oxford, UK and Clinical Skills Tutor…
1. NON-INTERVENTIONAL (NI) DRUG STUDY PROTOCOL STUDY OF THE UTILIZATION PATTERN OF APIXABAN IN THE NETHERLANDS 2. Ibrahim Y. Mahamoud Helene Saban Ravi Kasula…
1. Tyverb ®(lapatinib): Introduction and BackgroundTYV/SLK/08/39072/1 Date of preparation: Nov 2008 Prescribing information can be foundat the end of the full slide set…
Slide 1 Slide 2 Diltiazem Drug Interactions: A Quality Assessment of GeneMedRx Shannon C. OHara, Pharm.D. Candidate (2007) University of Washington School of Pharmacy Genelex…
Slide 1U.S. Regulation of Drug Development and the Role of The Information Professional Alberto Grignolo, Ph.D. Corporate VP and General Manager PAREXEL Consulting [email protected]…
Slide 1Regulation of Labeling and Promotion Edward P. Richards Harvey A. Peltier Professor of Law Louisiana State University School of Law [email protected] http://biotech.law.lsu.edu…
Slide 11 GCT9701 Please see Brief Summary and accompanying full Prescribing Information on slides 29-32. Indications may vary between countries. This piece is for promotional…